The third phase is after 2018, represented by the keywords “phenotypes,” “big data,” “magnetic resonance spectroscopy,” “renal cell carcinoma,” “stage,” “EGFR mutation,” “temozolomide,” and “artificial intelligence.” The gene discussed is EGFR; the disease is hereditary clear cell renal cell carcinoma.